Orpharm’s Mission is to provide a one-stop solution for rare and orphan products in the Russian & CIS markets. With compliance a hallmark of our business we provide a unique solution for your rare disease and oncology assets into the region. Orpharm is a member of the World Orphan Drug Alliance (WODA). WODA provides full-service solution to pharmaceutical & biotech companies with a portfolio of rare diseases, oncology and highly specialized therapeutics, starting from named patient programs to full commercialization. Visit us at https://www.woda-alliance.com/ WODA covers 68 countries in the following regions: - Central and Eastern Europe (Medis) - Latin America (OrphanDC) - Middle East, North Africa & Turkey (Vector Pharma) - Russia & the CIS region (Orpharm) - Switzerland (EffRx Pharmaceuticals)
